191 related articles for article (PubMed ID: 20559560)
1. Assay strategies for the discovery and validation of therapeutics targeting Brugia pahangi Hsp90.
Taldone T; Gillan V; Sun W; Rodina A; Patel P; Maitland K; O'Neill K; Chiosis G; Devaney E
PLoS Negl Trop Dis; 2010 Jun; 4(6):e714. PubMed ID: 20559560
[TBL] [Abstract][Full Text] [Related]
2. Hsp90 is essential in the filarial nematode Brugia pahangi.
Devaney E; O'neill K; Harnett W; Whitesell L; Kinnaird JH
Int J Parasitol; 2005 May; 35(6):627-36. PubMed ID: 15862576
[TBL] [Abstract][Full Text] [Related]
3. A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.
Gillan V; O'Neill K; Maitland K; Sverdrup FM; Devaney E
PLoS Negl Trop Dis; 2014 Feb; 8(2):e2699. PubMed ID: 24551261
[TBL] [Abstract][Full Text] [Related]
4. Antifilarial activity of caffeic acid phenethyl ester on Brugia pahangi in vitro and in vivo.
Al-Abd NM; Nor ZM; Junaid QO; Mansor M; Hasan MS; Kassim M
Pathog Glob Health; 2017 Oct; 111(7):388-394. PubMed ID: 29065795
[TBL] [Abstract][Full Text] [Related]
5. Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.
Weber H; Valbuena JR; Barbhuiya MA; Stein S; Kunkel H; García P; Bizama C; Riquelme I; Espinoza JA; Kurtz SE; Tyner JW; Calderon JF; Corvalán AH; Grez M; Pandey A; Leal-Rojas P; Roa JC
Oncotarget; 2017 Apr; 8(16):26169-26184. PubMed ID: 28412732
[TBL] [Abstract][Full Text] [Related]
6. Development of a fluorescence polarization assay for the molecular chaperone Hsp90.
Kim J; Felts S; Llauger L; He H; Huezo H; Rosen N; Chiosis G
J Biomol Screen; 2004 Aug; 9(5):375-81. PubMed ID: 15296636
[TBL] [Abstract][Full Text] [Related]
7. Yeast-Based High-Throughput Screens to Identify Novel Compounds Active against Brugia malayi.
Bilsland E; Bean DM; Devaney E; Oliver SG
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004401. PubMed ID: 26812604
[TBL] [Abstract][Full Text] [Related]
8. Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects.
Chan CT; Reeves RE; Geller R; Yaghoubi SS; Hoehne A; Solow-Cordero DE; Chiosis G; Massoud TF; Paulmurugan R; Gambhir SS
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2476-85. PubMed ID: 22895790
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.
Onuoha SC; Mukund SR; Coulstock ET; Sengerovà B; Shaw J; McLaughlin SH; Jackson SE
J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999
[TBL] [Abstract][Full Text] [Related]
10. Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors.
Beebe K; Mollapour M; Scroggins B; Prodromou C; Xu W; Tokita M; Taldone T; Pullen L; Zierer BK; Lee MJ; Trepel J; Buchner J; Bolon D; Chiosis G; Neckers L
Oncotarget; 2013 Jul; 4(7):1065-74. PubMed ID: 23867252
[TBL] [Abstract][Full Text] [Related]
11. Microarray-based screening of heat shock protein inhibitors.
Schax E; Walter JG; Märzhäuser H; Stahl F; Scheper T; Agard DA; Eichner S; Kirschning A; Zeilinger C
J Biotechnol; 2014 Jun; 180():1-9. PubMed ID: 24667540
[TBL] [Abstract][Full Text] [Related]
12. Improvement of inhibitor identification for heat shock protein 90α by utilizing a red-shifted fluorescence polarization probe.
Qian J; Holskin BP; Theroff J; Underiner T; Meyer SL; Angeles TS
Assay Drug Dev Technol; 2012 Aug; 10(4):375-81. PubMed ID: 22428803
[TBL] [Abstract][Full Text] [Related]
13. Geldanamycin-Derived HSP90 Inhibitors Are Synthetic Lethal with NRF2.
Baird L; Suzuki T; Takahashi Y; Hishinuma E; Saigusa D; Yamamoto M
Mol Cell Biol; 2020 Oct; 40(22):. PubMed ID: 32868290
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug.
Pallavi R; Roy N; Nageshan RK; Talukdar P; Pavithra SR; Reddy R; Venketesh S; Kumar R; Gupta AK; Singh RK; Yadav SC; Tatu U
J Biol Chem; 2010 Dec; 285(49):37964-75. PubMed ID: 20837488
[TBL] [Abstract][Full Text] [Related]
15. Potent cytotoxic C-11 modified geldanamycin analogues.
Tian ZQ; Wang Z; MacMillan KS; Zhou Y; Carreras CW; Mueller T; Myles DC; Liu Y
J Med Chem; 2009 May; 52(10):3265-73. PubMed ID: 19405528
[TBL] [Abstract][Full Text] [Related]
16. Expression of a unique drug-resistant Hsp90 ortholog by the nematode Caenorhabditis elegans.
David CL; Smith HE; Raynes DA; Pulcini EJ; Whitesell L
Cell Stress Chaperones; 2003; 8(1):93-104. PubMed ID: 12820659
[TBL] [Abstract][Full Text] [Related]
17. P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response.
McCollum AK; TenEyck CJ; Stensgard B; Morlan BW; Ballman KV; Jenkins RB; Toft DO; Erlichman C
Cancer Res; 2008 Sep; 68(18):7419-27. PubMed ID: 18794130
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the mTOR-raptor signaling pathway by the inhibitor of heat shock protein 90 geldanamycin.
Ohji G; Hidayat S; Nakashima A; Tokunaga C; Oshiro N; Yoshino K; Yokono K; Kikkawa U; Yonezawa K
J Biochem; 2006 Jan; 139(1):129-35. PubMed ID: 16428328
[TBL] [Abstract][Full Text] [Related]
19. Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway.
Kimura T; Uesugi M; Takase K; Miyamoto N; Sawada K
Toxicol Appl Pharmacol; 2017 Aug; 329():282-292. PubMed ID: 28624441
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma.
Khaledian B; Taguchi A; Shin-Ya K; Kondo-Ida L; Kagaya N; Suzuki M; Kajino T; Yamaguchi T; Shimada Y; Takahashi T
Cancer Sci; 2021 Mar; 112(3):1225-1234. PubMed ID: 33370472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
